Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting
出版年份 2014 全文链接
标题
Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 26, Issue 3, Pages 217-222
出版商
Informa UK Limited
发表日期
2014-06-12
DOI
10.3109/09546634.2014.933166
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis
- (2013) Nuria Palau et al. BMC GENOMICS
- Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
- (2013) Clara De Simone et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals
- (2012) U. Mrowietz et al. BRITISH JOURNAL OF DERMATOLOGY
- Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
- (2012) J. Leman et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term response to etanercept monotherapy in moderate to severe psoriasis: assessment in daily practice by the maintenance of low values of PASI and BSA
- (2012) Rosa María Fernández-Torres et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study
- (2012) K. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Is ‘class effect’ relevant when assessing the benefit/risk profile of a biologic agent?
- (2012) W. Sterry et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
- (2011) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
- (2011) Kenneth Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab for psoriasis in Greece: clinical experience in a tertiary referral centre
- (2011) C. Fotiadou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE
- (2011) J.-P. Ortonne et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study
- (2010) R.T. Woolf et al. BRITISH JOURNAL OF DERMATOLOGY
- Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
- (2010) P.P.M. Van Lümig et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept
- (2010) Robert Bissonnette et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
- (2009) G. M. Bartelds et al. ANNALS OF THE RHEUMATIC DISEASES
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
- (2009) C.H. Smith et al. BRITISH JOURNAL OF DERMATOLOGY
- Experience with biologics for psoriasis in daily practice: switching is worth a try
- (2009) L.L.A. Lecluse et al. BRITISH JOURNAL OF DERMATOLOGY
- Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome
- (2009) R.J.B. Driessen et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab treatment for severe recalcitrant chronic plaque psoriasis
- (2009) C. Ryan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- The Reason for Discontinuation of the First Tumor Necrosis Factor (TNF) Blocking Agent Does Not Influence the Effect of a Second TNF Blocking Agent in Patients with Rheumatoid Arthritis
- (2009) M. BLOM et al. JOURNAL OF RHEUMATOLOGY
- Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation
- (2009) CL Martyn-Simmons et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
- (2009) Andrea Rubbert-Roth et al. ARTHRITIS RESEARCH & THERAPY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started